LY3405105
LY3405105 is a novel, potent, and selective inhibitor of cyclin-dependent kinase 7 (CDK7) . This small molecule is used in biochemical and cellular research to investigate CDK7's roles in transcription and cell cycle progression, with studies demonstrating its activity in both in vitro assays and in vivo cancer models.
Product Specifications
CAS Number
2326428-25-3
Product Name Alternative
SNU-16, inhibit, LY 3405105, LY3405105, LY-3405105, MCF7, Inhibitor, HCC1806, HCT116, anticancer, 1-Piperidinecarboxylic acid, 4-[[5-methyl-3- (1-methylethyl) pyrazolo[1,5-a]pyrimidin-7-yl]amino]-, 1-[ (2E) -4- (dimethylamino) -1-oxo-2-buten-1-yl]-3-pyrrolidinyl ester, CDK7, CDK, Cyclin-dependent kinase, Cyclin dependent kinase
Field of Research
Cell Biology
Purity
98.01% (May vary between batches)
Solubility
DMSO:4.98 mg/mL (10.01 mM)
Smiles
C (C) (C) C1=C2N (C (NC3CCN (C (OC4CN (C (/C=C/CN (C) C) =O) CC4) =O) CC3) =CC (C) =N2) N=C1
Molecular Formula
C26H39N7O3
Molecular Weight
497.63
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-61866R-BF405 100 µL
GIT1 Recombinant Antibody, AbBy Fluor™ 405 Conjugated
Sign In for Pricing
View Details 
RC204866L1 10 µg
GDNF Receptor alpha 1 (GFRA1) (NM_145793) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details